NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



DNA Research



Scientists at Emory University, Emory Vaccine Center publish new data on DNA research



January 14th, 2009

According to recent research from the United States, "DNA-dependent activator of IFN regulatory factors (IRF; DAI, also known as ZBP1 or DLM-1) is a cytosolie DNA sensor that initiates IRF3 and NF-kappa B pathways leading to activation of type I IFNs (IFN alpha, IFN beta) and other cytokines. In this study, induction of NF-kappa B is shown to depend on the adaptor receptor-interacting protein kinase (RIP)I, acting via a RIP homotypic interaction motif (RHIM)-dependent interaction with DAI."

"DAI binds to and colocalizes with endogenous RIP1 at characteristic cytoplasmic granules. Suppression of RIP1 expression by RNAi abrogates NF-kappa B activation as well as IFN beta...


Source: Vaccine Weekly (2009-01-14)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login